Trading Markets.com
DNA testing services company Orchid Cellmark Inc (Nasdaq: ORCH | PowerRating) stated on Thursday the receipt of a total estimated annual contract valued at approximately USD1.2m under the latest National Forensic Procurement regional tender.
Orchid Cellmark Inc announces expansion of DNA analysis footprint across UK
This entry was posted in Uncategorized. Bookmark the permalink.